Paul Tudor Jones's IDXX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 8,342 shares of IDEXX Laboratories, Inc. (IDXX) worth $4.69 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in IDXX, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 36,086 shares. Largest reduction occurred in Q2 2025, reducing 20,125 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's IDEXX Laboratories (IDXX) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEXX Laboratories (IDXX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +8,342 | New Buy | 8,342 | $561.89 |
| Q4 2025 | -6,614 | Sold Out | 0 | $0.00 |
| Q3 2025 | -11,313 | Reduce 63.11% | 6,614 | $638.89 |
| Q2 2025 | -20,125 | Reduce 52.89% | 17,927 | $536.34 |
| Q1 2025 | +36,086 | Add 1835.50% | 38,052 | $419.95 |
| Q4 2024 | +1,966 | New Buy | 1,966 | $413.44 |
| Q3 2024 | -1,280 | Sold Out | 0 | $0.00 |
| Q2 2024 | +1,280 | New Buy | 1,280 | $487.20 |
| Q4 2023 | -2,402 | Sold Out | 0 | $0.00 |
| Q3 2023 | -10,991 | Reduce 82.07% | 2,402 | $437.27 |
| Q2 2023 | +13,393 | New Buy | 13,393 | $502.23 |
| Q1 2023 | -11,982 | Sold Out | 0 | $0.00 |
| Q4 2022 | +7,750 | Add 183.13% | 11,982 | $0.41 |
| Q3 2022 | -7,387 | Reduce 63.58% | 4,232 | $325.85 |
| Q2 2022 | +11,619 | New Buy | 11,619 | $350.72 |
| Q4 2021 | -5,911 | Sold Out | 0 | $0.00 |
| Q3 2021 | +5,911 | New Buy | 5,911 | $621.89 |
| Q2 2021 | -6,549 | Sold Out | 0 | $0.00 |
| Q1 2021 | -4,155 | Reduce 38.82% | 6,549 | $489.23 |
| Q4 2020 | +4,138 | Add 63.02% | 10,704 | $499.91 |
| Q3 2020 | +3,103 | Add 89.60% | 6,566 | $393.09 |
| Q2 2020 | -1,328 | Reduce 27.72% | 3,463 | $330.06 |
| Q1 2020 | +4,791 | New Buy | 4,791 | $242.33 |
| Q4 2018 | -3,032 | Sold Out | 0 | $0.00 |
| Q3 2018 | -780 | Reduce 20.46% | 3,032 | $249.67 |
| Q2 2018 | +2,405 | Add 170.93% | 3,812 | $218.00 |
| Q1 2018 | -3,117 | Reduce 68.90% | 1,407 | $191.19 |
| Q4 2017 | +4,524 | New Buy | 4,524 | $156.28 |
| Q4 2016 | -4,599 | Sold Out | 0 | $0.00 |
| Q3 2016 | -1,113 | Reduce 19.49% | 4,599 | $112.63 |
| Q2 2016 | +5,712 | New Buy | 5,712 | $92.79 |
| Q4 2015 | -10,711 | Sold Out | 0 | $0.00 |
| Q3 2015 | -19 | Reduce 0.18% | 10,711 | $74.22 |
| Q2 2015 | +10,730 | New Buy | 10,730 | $64.12 |
| Q1 2015 | -4,400 | Sold Out | 0 | $0.00 |
| Q4 2014 | -16,682 | Reduce 79.13% | 4,400 | $74.09 |
| Q3 2014 | +17,882 | Add 558.81% | 21,082 | $58.91 |
| Q2 2014 | +3,200 | New Buy | 3,200 | $66.88 |
| Q1 2014 | -4,814 | Sold Out | 0 | $0.00 |
| Q4 2013 | +4,814 | New Buy | 4,814 | $53.18 |
| Q3 2013 | -6,000 | Sold Out | 0 | $0.00 |
| Q2 2013 | +6,000 | Add 0.00% | 6,000 | $44.83 |
Paul Tudor Jones's IDEXX Laboratories Investment FAQs
Paul Tudor Jones first purchased IDEXX Laboratories, Inc. (IDXX) in Q2 2013, acquiring 6,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held IDEXX Laboratories, Inc. (IDXX) for 42 quarters since Q2 2013.
Paul Tudor Jones's largest addition to IDEXX Laboratories, Inc. (IDXX) was in Q1 2025, adding 38,052 shares worth $15.98 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 8,342 shares of IDEXX Laboratories, Inc. (IDXX), valued at approximately $4.69 M.
As of the Q1 2026 filing, IDEXX Laboratories, Inc. (IDXX) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in IDEXX Laboratories, Inc. (IDXX) was 38,052 shares, as reported at the end of Q1 2025.